• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Enzolytics Inc (OP: ENZC )

    0.0012 -0.0001 (-7.69%)
    Streaming Delayed Price Updated: 3:42 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 13,466,884
    Open 0.0012
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0013
    Today's Range 0.0011 - 0.0014
    52wk Range 0.0010 - 0.0270
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator
    Via ACCESSWIRE
    Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement
    Via ACCESSWIRE

    Performance

    YTD
    -93.81%
    -93.81%
    1 Month
    -29.41%
    -29.41%
    3 Month
    -70.73%
    -70.73%
    6 Month
    -72.09%
    -72.09%
    1 Year
    -95.44%
    -95.44%

    More News

    Read More
    Final Report From the National Centre of Infectious and Parasitic Diseases Concludes Lyophilized Pepsin Significantly Reduces the Survival and Proliferation of Growth in Specific Cancer Cells
    Via ACCESSWIRE
    Penny Stocks to Watch August 2024: SPZI, RJDG, HIRU, AABB more inside…
    Via AB Newswire
    Enzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS Applications
    Via ACCESSWIRE
    Enzolytics, Inc. Enters Into Collaboration Agreement With Manufacturer Elimus Ltd.
    Via ACCESSWIRE
    Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment
    Via ACCESSWIRE
    Enzolytics, Inc. Announces Letter of Intent for Exclusive Licensing Agreement for Patented Nitric Oxide Formulation
    Via ACCESSWIRE
    Enzolytics Inc. Supports Sagaliam Acquisition Corp Response to Competitors False and Misleading Press Release
    Via ACCESSWIRE
    Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology
    Via ACCESSWIRE
    Spotlight: Stocks Under One Penny Key Updates SPZI, HNRC, ENZC, HALB, BIEI
    Via AB Newswire
    Topics Intellectual Property
    Exposures Intellectual Property
    Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment
    Via ACCESSWIRE
    Enzolytics Inc. Announces Dismissal of The Dimitar Savov Lawsuit in Nevada
    Via ACCESSWIRE
    Update on Formulation of New Business Strategy
    Via ACCESSWIRE
    Enzolytics Announces the Signing of the Business Combination Agreement with Sagaliam Acquisition Corp (SAGA)
    Via ACCESSWIRE
    Patient Population for the Clinical Trials of ITV-1 has been Established by the European Medicines Agency ("EMA")
    Via ACCESSWIRE
    Stocks Under 5¢ To Watch Now! HNRC, HALB, ENZC, SNNC, SPZI
    Via AB Newswire
    Topics Artificial Intelligence Economy
    Exposures Artificial Intelligence Economy
    OTC Stocks to Watch in February: CLNV, HNRC, ENZC, GEVI, PBIO
    Via AB Newswire
    Topics Artificial Intelligence Bonds
    Exposures Artificial Intelligence Debt Markets
    “Exploring Market Opportunities Stocks to Watch Under 5¢ Now: CLNV, ENZC, HNRC, HALB, SPZI”
    Via AB Newswire
    Topics Artificial Intelligence Energy
    Exposures Artificial Intelligence Fossil Fuels
    Enzolytics, Inc. Announces Partnership With the Khalpey AI Lab To Forge the Future of Multi-Organ Remodeling and Rejuvenation With a Strategic Focus on Longevity
    Via ACCESSWIRE
    Penny Stocks, Shifts in Trends, Notable Performances, and Strategic Developments, Opportunities: CLNV, HALB, SPZI, HNRC, ENZC
    Via AB Newswire
    Topics Bonds Economy
    Exposures Debt Markets Economy
    Virogentics, Inc. Receives Permit for Export to Africa of the ITV-1 Immunotherapy Solidifying the Scheduled Administration of the Treatment
    Via ACCESSWIRE
    Enzolytics, Inc. Files Amended December 31, 2022 OTC Report with Audited Financials and Unaudited September 30, 2023 Quarterly Disclosure
    Via ACCESSWIRE
    Biogenysis, Inc. Announces Partnering with Khalpey AI Lab and Contenta, Ltd. to Incorporate AI in Microbiome Analysis to Identify Biomarkers for Use in Accurately Predicting Alzheimer's Disease Onset and Prevention.
    Via ACCESSWIRE
    Biogenysis’ International Patent Application, Covering Its Anti-SARS-CoV-2 Monoclonal Antibodies, Advances to Prosecution in Europe and as a U.S. National Stage Application.
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.